Literature DB >> 2328412

Acute infantile spinal muscular atrophy. Muscle apoptosis as a proposed pathogenetic mechanism.

A Fidziańska1, H H Goebel, I Warlo.   

Abstract

Biopsy as well as autopsy studies of a child who died 8 weeks after birth from the acute infantile form of spinal muscular atrophy revealed classical morphological changes, including degeneration and loss of motoneurons in the spinal cord, loss of large myelinated fibres in anterior roots and neurogenic atrophy in muscle. New ultrastructural findings include massive muscle cell elimination by apoptosis with the formation of membrane-bound muscle cell fragments, apoptotic bodies. In addition, numerous immature muscle fibres were observed. The morphological findings raise the possibility that in a severely growth-retarded muscle, the process of muscle cell apoptosis removes the peripheral target of anterior horn cells resulting in secondary motoneuron death.

Entities:  

Mesh:

Year:  1990        PMID: 2328412     DOI: 10.1093/brain/113.2.433

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  17 in total

1.  Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Authors:  Tara L Martinez; Lingling Kong; Xueyong Wang; Melissa A Osborne; Melissa E Crowder; James P Van Meerbeke; Xixi Xu; Crystal Davis; Joe Wooley; David J Goldhamer; Cathleen M Lutz; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases.

Authors:  T Koseki; N Inohara; S Chen; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

Review 3.  Apoptosis of skeletal muscle cells and the pathogenesis of myositis: a perspective.

Authors:  C C Liu; J M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2001-08       Impact factor: 4.592

4.  Modulation of antioxidant enzymes and apoptosis in mice by dietary lipids and treadmill exercise.

Authors:  C P Avula; G Fernandes
Journal:  J Clin Immunol       Date:  1999-01       Impact factor: 8.317

5.  SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents.

Authors:  H Duan; Y Wang; M Aviram; M Swaroop; J A Loo; J Bian; Y Tian; T Mueller; C L Bisgaier; Y Sun
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

6.  Deficiency of the Bax gene attenuates denervation-induced apoptosis.

Authors:  P M Siu; S E Alway
Journal:  Apoptosis       Date:  2006-06       Impact factor: 4.677

7.  Increased IGF-1 in muscle modulates the phenotype of severe SMA mice.

Authors:  Marta Bosch-Marcé; Claribel D Wee; Tara L Martinez; Celeste E Lipkes; Dong W Choe; Lingling Kong; James P Van Meerbeke; Antonio Musarò; Charlotte J Sumner
Journal:  Hum Mol Genet       Date:  2011-02-16       Impact factor: 6.150

8.  Neural stem cell transplantation can ameliorate the phenotype of a mouse model of spinal muscular atrophy.

Authors:  Stefania Corti; Monica Nizzardo; Martina Nardini; Chiara Donadoni; Sabrina Salani; Dario Ronchi; Francesca Saladino; Andreina Bordoni; Francesco Fortunato; Roberto Del Bo; Dimitra Papadimitriou; Federica Locatelli; Giorgia Menozzi; Sandra Strazzer; Nereo Bresolin; Giacomo P Comi
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

9.  Inhibition of myostatin does not ameliorate disease features of severe spinal muscular atrophy mice.

Authors:  Charlotte J Sumner; Claribel D Wee; Leigh C Warsing; Dong W Choe; Andrew S Ng; Cathleen Lutz; Kathryn R Wagner
Journal:  Hum Mol Genet       Date:  2009-05-28       Impact factor: 6.150

10.  Trichostatin A increases SMN expression and survival in a mouse model of spinal muscular atrophy.

Authors:  Amy M Avila; Barrington G Burnett; Addis A Taye; Francesca Gabanella; Melanie A Knight; Parvana Hartenstein; Ziga Cizman; Nicholas A Di Prospero; Livio Pellizzoni; Kenneth H Fischbeck; Charlotte J Sumner
Journal:  J Clin Invest       Date:  2007-02-22       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.